CS logo
small CS logo
KEM Hospital Research Centre

Pune, Maharashtra, India
General hospital in Pune, Maharashtra
489, Mudaliar Rd, Rasta Peth, Pune, Maharashtra 411011

About KEM Hospital Research Centre


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at KEM Hospital Research Centre


During the past decade, KEM Hospital Research Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
2001-11-29
2004-01-15
Completed
569
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
2003-02-01
2013-08-01
Completed
470
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2004-03-01
2010-07-01
Completed
1,300
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
2004-09-01
2022-05-01
Unknown status
600
A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum
2001-07-01
2011-05-01
Completed
326

Rows per page:

1–71 of 71

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "KEM Hospital Research Centre" #1 sponsor was "Pfizer" with 3 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Shire" with 2 trials sponsored and "Asahi Kasei Pharma America Corporation" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "KEM Hospital Research Centre" #1 collaborator was "All India Institute of Medical Sciences, New Delhi" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "KEM Hospital Research Centre" with 1 trials as a collaborator and "Mulago Hospital, Uganda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at KEM Hospital Research Centre


According to Clinical.Site data, the most researched conditions in "KEM Hospital Research Centre" are "Colitis, Ulcerative" (2 trials), "Gaucher Disease, Type 1" (2 trials), "Gaucher Disease, Type 3" (2 trials), "Vaccines" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "KEM Hospital Research Centre" in a lesser frequency.

Clinical Trials Intervention Types at KEM Hospital Research Centre


Most popular intervention types in "KEM Hospital Research Centre" are "Drug" (15 trials), "Biological" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "13vPnC" (2 trials), "Etrolizumab" (2 trials), "placebo" (2 trials) and "velaglucerase alfa" (2 trials). Other intervention names were less common.

Clinical Trials Genders at KEM Hospital Research Centre


The vast majority of trials in "KEM Hospital Research Centre" are 21 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at KEM Hospital Research Centre


Currently, there are NaN active trials in "KEM Hospital Research Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in KEM Hospital Research Centre, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in KEM Hospital Research Centre, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status